Examiner: ALFANO, ALAN

Tech Center 1600 • Art Units: 1641

This examiner grants 0% of resolved cases

Performance Statistics

Allow Rate

-60.0% vs TC avg

Total Applications

Interview Lift

1175

Avg Prosecution Days

Based on 0 resolved cases, 2023–2026

14.3%

§101 Eligibility

14.3%

§102 Novelty

38.1%

§103 Obviousness

33.3%

§112 Clarity

App #	Title	Status	Assignee
18448842	COMPOSITIONS AND METHODS RELATED TO IMMUNOGLOBULIN PROTEASES AND FUSIONS THEREOF	Non-Final OA	Cartesian Therapeutics, Inc.
17907116	AUTONOMOUS KNOB DOMAIN PEPTIDES	Non-Final OA	UCB BIOPHARMA SRL
18213205	METHOD FOR INDUCING ANTIGEN-SPECIFIC T CELL AND USE THEREOF IN TREATING CANCER OR VIRUS INFECTION	Final Rejection	FullHope Biomedical Co., Ltd

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.